Glycemic Thresholds for Diabetes-Specific Retinopathy
Open accessThe DOI matches its Crossref record, with a small difference in title or year; 26 of the 26 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: To re-evaluate the relationship between glycemia and diabetic retinopathy. RESEARCH DESIGN AND METHODS: We conducted a data-pooling analysis of nine studies from five countries with 44,623 participants aged 20–79 years with gradable retinal photographs. The relationship between diabetes-specific retinopathy (defined as moderate or more severe retinopathy) and three glycemic measures (fasting plasma glucose [FPG; n = 41,411], 2-h post oral glucose load plasma glucose [2-h PG; n = 21,334], and A1C [n = 28,010]) was examined. RESULTS: When diabetes-specific retinopathy was plotted against continuous glycemic measures, a curvilinear relationship was observed for FPG and A1C. Diabetes-specific retinopathy prevalence was low for FPG <6.0 mmol/l and A1C <6.0% but increased above these levels. Based on vigintile (20 groups with equal numbers) distributions, glycemic thresholds for diabetes-specific retinopathy were observed over the range of 6.4–6.8 mmol/l for FPG, 9.8–10.6 mmol/l for 2-h PG, and 6.3–6.7% for A1C. Thresholds for diabetes-specific retinopathy from receiver-operating characteristic curve analyses were 6.6 mmol/l for FPG, 13.0 mmol/l for 2-h PG, and 6.4% for A1C. CONCLUSIONS: This study broadens the evidence based on diabetes diagnostic criteria. A narrow threshold range for diabetes-specific retinopathy was identified for FPG and A1C but not for 2-h PG. The combined analyses suggest that the current diabetes diagnostic level for FPG could be lowered to 6.5 mmol/l and that an A1C of 6.5% is a suitable alternative diagnostic criterion.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Importantly, evidence indicates that HbA1c, or fasting glucose, are stronger predictors of vascular complications than 2 h OGTT and it is therefore best to adopt these simple measures for general screening, particularly given their high reproducibility.[35][36][37][38]”
From 2023 ESC guidelines for the management of cardiovascular disease in patients with diabetes. (2023) · cites this paper as [36]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus* (2002) · Diabetes Care · doi:10.2337/diacare.25.2007.s5 · Cited by 10,338
Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (1997) · Diabetes Care · doi:10.2337/diacare.20.7.1183 · Cited by 6,220
(1991) · Ophthalmology · doi:10.1016/s0161-6420(13)38012-9 · Cited by 2,048
Unwin, N. C. (2006) · Cited by 1,661
Full accounting of diabetes and pre-diabetes in the U.S. population in 1988–1994 and 2005–2006
Cowie, C. C., Rust, K. F., Ford, E. S., Eberhardt, M. S., Byrd-Holt, D. D., Li, C., Williams, D. E., Gregg, E. W., Bainbridge, K. E., Saydah, S. H., et al. (2009) · Diabetes Care · doi:10.2337/dc08-1296 · Cited by 1,154 · cited 1×
“This has been an ongoing issue with the current diagnostic criteria whereby using FPG alone or an OGTT to diagnose diabetes, give different diabetes prevalence (23).”
BackgroundDiabetic Retinopathy in a Multi-ethnic Cohort in the United States
Wong, T. Y., Klein, R., Islam, F. M. A., Cotch, M. F., Folsom, A. R., Klein, B. E. K., Sharrett, A. R., & Shea, S. (2006) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2005.08.063 · Cited by 684 · cited 1×
“All nine studies measured plasma glucose, and six studies that measured A1C used high-performance liquid chromatography, of which five used a Diabetes Control and Complicat ions Trial (DCCT)-aligned assay (5,12,14,15,18).”
MethodSelf-citationMcCane, D. R., Hanson, R. L., Charles, M. A., Jacobsson, L. T. H., Pettitt, D. D., Bennett, P. H., & Knowler, W. C. (1994) · BMJ · doi:10.1136/bmj.308.6940.1323 · Cited by 484
Harris, M. I., Klein, R., Cowie, C. C., Rowland, M., & Byrd-Holt, D. D. (1998) · Diabetes Care · doi:10.2337/diacare.21.8.1230 · Cited by 401 · cited 2×
“All nine studies measured plasma glucose, and six studies that measured A1C used high-performance liquid chromatography, of which five used a Diabetes Control and Complicat ions Trial (DCCT)-aligned assay (5,12,14,15,18).”
BackgroundMethod
Research works printed but not linked: 2
- Colagiuri, 2003, DETECT-2: early detection of type 2 diabetes and IGT, Diabetes Voice, 48, 11
- Diabetic Retinopathy Study Research Group, 1981, Report 7. A modification of the Airlie House classification of diabetic retinopathy, Invest Ophthalmol Vis Sci, 21, 210
Cited by
Items 101–200 of 342
Cutoff Point of HbA1c for Diagnosis of Diabetes Mellitus in Chinese Individuals
Wang, B., Liu, M.-C., Li, X., Liu, X., Feng, Q.-X., Lu, L., Zhu, Z., Liu, Y., Zhao, W., & Gao, Z. (2016) · PLoS ONE · doi:10.1371/journal.pone.0166597 · Cited by 27
Park, Y., Ko, S., Lee, J.-M., Kim, D. J., Kim, D. J., Han, K., Bower, J. K., & Ahn, Y. (2014) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2014.04.003 · Cited by 27
Sattar, N. A., & Preiss, D. (2012) · Diabetologia · doi:10.1007/s00125-012-2510-8 · Cited by 26
Rodacki, M., Zajdenverg, L., Júnior, W. S. D. S., Giacaglia, L. R., Negrato, C. A., Cobas, R. A., de Almeida-Pititto, B., & Bertoluci, M. C. (2025) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-024-01572-w · Cited by 25
Glucose: Archetypal Biomarker in Diabetes Diagnosis, Clinical Management and Research
Krentz, A. J., & Hompesch, M. (2016) · Biomarkers in Medicine · doi:10.2217/bmm-2016-0170 · Cited by 25
Tamara, A., Coulson, D. J., Latief, J. S., Bakhashab, S., & Weaver, J. U. (2021) · Stem Cell Research & Therapy · doi:10.1186/s13287-021-02332-7 · Cited by 25
“To validate our original finding, the values of HbA1c used to define the diabetes state are equally defined by the development of microvascular complication [48, 49].”
BackgroundMethodXu, N., Wu, H., Li, D., & Wang, J. (2014) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2014.04.010 · Cited by 25
“Furthermore, HbA1c levels are consistent with blood glucose levels and diabetes-related complications [8,9].”
BackgroundKhan, H. A., Ola, M. S., Alhomida, A. S., Sobki, S. H., & Khan, S. A. (2013) · Endocrine Research · doi:10.3109/07435800.2013.828740 · Cited by 25
Glucokinase MODY and Implications for Treatment Goals of Common Forms of Diabetes
Ajjan, R., & Owen, K. R. (2014) · Current Diabetes Reports · doi:10.1007/s11892-014-0559-0 · Cited by 25
Sattar, N. A., & Preiss, D. (2016) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(16)00085-1 · Cited by 24
Implications of using HBA1C as a diagnostic marker for diabetes
Hussain, N. (2015) · Diabetology International · doi:10.1007/s13340-015-0244-9 · Cited by 24
Ussif, A., Åsberg, A., Halden, T. A. S., Nordheim, E., Hartmann, A., & Jenssen, T. G. (2019) · BMC Nephrology · doi:10.1186/s12882-018-1171-3 · Cited by 24
HbA1c in der Diabetesdiagnostik
Landgraf, R. (2021) · Diabetes aktuell · doi:10.1055/a-1306-8016 · Cited by 24
“Der Diagnose-Schwellenwert für einen Diabetes wurde auf einen Wert von ≥ 48 mmol/mol Hb (≥ 6,5 %) festgelegt [45, 46].”
BackgroundHutchinson, M. S., Joakimsen, R. M., Njølstad, I., Schirmer, H., Figenschau, Y., & Jorde, R. (2012) · PubMed · doi:10.3275/8191 · Cited by 24
HbA1c and diagnosis of diabetes. The test has finally come of age
Day, A. (2012) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1258/acb.2011.011255 · Cited by 24
Gerstein, H. C., Smith, E. E., Ramasundarahettige, C. F., Desai, D., Awadalla, P., Broët, P., Black, S. E., Dummer, T., Hicks, J., Moody, A. R., et al. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa815 · Cited by 23
Fallstricke bei der Diabetesdiagnostik: Wird zu lax mit Laborwerten umgegangen?
Landgraf, R., Nauck, M. A., Freckmann, G., Müller, U. A., Heinemann, L., Kellerer, M., & Müller‐Wieland, D. (2018) · DMW - Deutsche Medizinische Wochenschrift · doi:10.1055/a-0673-2156 · Cited by 23
Gholap, N. N., Davies, M. J., Mostafa, S. A., & Khunti, K. (2013) · British Journal of General Practice · doi:10.3399/bjgp13x663244 · Cited by 23
Kirthi, V., Reed, K. I., Alattar, K., Zuckerman, B. P., Bunce, C., Nderitu, P., Alam, U., Clarke, B., Hau, S., Al‐Shibani, F., et al. (2022) · Diabetic Medicine · doi:10.1111/dme.14952 · Cited by 22
Shah, M. U., Roebuck, A., Srinivasan, B., Ward, J. K., Squires, P. E., Hills, C. E., & Lee, K. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1499681 · Cited by 23
Monogenic diabetes and pregnancy
Murphy, R. (2015) · Obstetric Medicine · doi:10.1177/1753495x15590713 · Cited by 22
“Diabetes is diagnosed by either elevated blood glucose or HbA1c values based on thresholds associated with a substantially increased risk of microvascular complications, particularly retinopathy among several cross-sectional epidemiology studies.(2) The thresholds for diagnostic fasting blood glucose is 7.”
BackgroundDéfinition, classification et diagnostic du diabète, du prédiabète et du syndrome métabolique
Goldenberg, R., & Punthakee, Z. (2013) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2013.07.031 · Cited by 22
Aidenloo, N. S., Mehdizadeh, A., Valizadeh, N., Abbaszadeh, M. E., Qarequran, S., & Khalkhali, H. R. (2016) · Iranian Red Crescent Medical Journal · doi:10.5812/ircmj.31254 · Cited by 21
Prevalence of Prediabetes and Undiagnosed Diabetes Among Kuwaiti Adults: A Cross-Sectional Study
Mohammad, A., Ziyab, A. H., & Mohammad, T. (2021) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s296848 · Cited by 22
“For instance, in the DETECT-2 study (~45,000 participants), neither the OGTT, HbA1c, nor FPG showed an advantage over the others in identifying diabetes-specific retinopathy.(42) As for undiagnosed T2DM, data from the NHANES study showed that the prevalence of undiagnosed T2DM differed according to the type of the tes…”
ResultSchulze, M. B., & Hu, F. B. (2013) · Springer eBooks · doi:10.1007/978-0-387-09834-0_66 · Cited by 21
Metcalf, P., Kyle, C., Kenealy, T. W., & Jackson, R. (2017) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2017.02.007 · Cited by 21
“Others have reported linear or curvilinear associations between elevated HbA1c levels and diabetes diagnosis (Selvin et al. 2010; Pradhan et al. 2007; Nakagami et al. 2010), retinopathy (Colagiuri et al. 2011), microalbuminuria (Tapp et al.”
BackgroundInfluentialBakke, Å., Tran, A. T., Dalen, I., Cooper, J. G., Løvaas, K. F., Jenum, A. K., Berg, T. J., Madsen, T. V., Nøkleby, K., Gjelsvik, B., et al. (2018) · Diabetic Medicine · doi:10.1111/dme.13842 · Cited by 20
Atkin, S. L., Butler, A. E., Hunt, S. C., & Kilpatrick, E. S. (2021) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14449 · Cited by 20
Parameswarappa, D. C., Rajalakshmi, R., Mohamed, A., Kavya, S., Munirathnam, H., Manayath, G. J., Kumar, M., Raman, R., Vignesh, T. P., Ramasamy, K., et al. (2021) · Indian Journal of Ophthalmology · doi:10.4103/ijo.ijo_1459_21 · Cited by 20
Nguyen, K. A., Daniel, M., Zhao, Y. W., Sekgala, M. D., Kallakuri, S., Hill, J., Joshi, R., Kengne, A. P., & Peer, N. (2025) · BMJ Global Health · doi:10.1136/bmjgh-2025-018939 · Cited by 19
LDL-Cholesterol versus Glucose in Microvascular and Macrovascular Disease
Emanuelsson, F., & Benn, M. (2020) · Clinical Chemistry · doi:10.1093/clinchem/hvaa242 · Cited by 19
Prevalence of Retinopathy in Prediabetic Populations: A Systematic Review and Meta-Analysis
Sune, M. P., Sune, M., Sune, P. G., & Dhok, A. (2023) · Cureus · doi:10.7759/cureus.49602 · Cited by 19
“DETECT-2 demonstrated a relationship between HbA1c and OGTT similar to OGTT [60-63].”
MethodTools for practice: screening and diagnosis of type 2 diabetes with HbA1c.
Mannarino, M., Tonelli, M. A., & Allan, G. M. (2013) · Europe PMC (PubMed Central) · Cited by 19
Hutchinson, M. S., Joakimsen, R. M., Njølstad, I., Schirmer, H., Figenschau, Y., Svartberg, J. B., & Jorde, R. (2013) · International Journal of Endocrinology · doi:10.1155/2013/613475 · Cited by 19
Ye, X., Zong, G., Liu, X., Liu, G., Gan, W., Zhu, J., Lu, L., Sun, L. D., Li, H., Hu, F. B., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0097042 · Cited by 19
“5% should be used as a cut-off point for diagnosing diabetes still remains controversial, because some studies suggest that HbA1c levels can vary among different ethnic/ racial groups [25,26].”
BackgroundMiller, E. M., & Miller, K. (2024) · Clinical Diabetes · doi:10.2337/cd23-0077 · Cited by 18
Takao, T., Inoue, K., Suka, M., Yanagisawa, H., & Iwamoto, Y. (2018) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2018.03.051 · Cited by 18
Is HbA1c a valid and feasible tool for the diagnosis of diabetes?
Kowall, B., Rathmann, W., & Landgraf, R. (2011) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2011.06.024 · Cited by 17
Hobabagabo, A. F., OSEI-TUTU, N. H., Hormenu, T., SHOUP, E. M., DuBose, C. W., Mabundo, L. S., Ha, J., Sherman, A., Chung, S. T., Sacks, D. B., et al. (2020) · Diabetes Care · doi:10.2337/dc20-1119 · Cited by 17
Reconsidering the HbA1c Cutoff for Diabetes Diagnosis Based on a Large Chinese Cohort
Qi, J., Su, Y., Song, Q., Ding, Z., Cao, M., Cui, B., & Qi, Y. (2019) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/a-0833-8119 · Cited by 17
Wang, J., Lee, I., Lee, W., Lin, S., Fu, C., Lee, W.-L., Liang, K., & Sheu, W. H. (2014) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2014-0860 · Cited by 17
Shephard, M., Shephard, A., McAteer, B., Regnier, T., & Barancek, K. (2017) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2017.07.007 · Cited by 16
Toledo‐Corral, C. M., Vargas, L. G., Goran, M. I., & Weigensberg, M. J. (2011) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2011.10.024 · Cited by 16
Kweon, S., Park, S. J., Lee, H. K., Kang, S. H., Chang, K.-Y., Choi, J. U., Park, J., Shim, J., Park, J. W., & Byun, Y. (2024) · International Journal of Nanomedicine · doi:10.2147/ijn.s442617 · Cited by 16
Characterization of Turner Syndrome-associated Diabetes Mellitus
Cameron‐Pimblett, A., Rosa, C. L., Davies, M. C., Suntharalingham, J. P., Ishida, M., Achermann, J. C., & Conway, G. S. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae357 · Cited by 16
“The 2 tests, however, were similarly effective in predicting the progression to DM complications The Journal of Clinical Endocrinology & Metabolism , 2024, Vol. 00, No. 0 such as retinopathy in the DIRECT-2 project (27).”
Implications of Risk Stratification for Diabetes Prevention
Gregg, E. W., Geiss, L. S., Zhang, P., Zhuo, X., Williamson, D. F., & Albright, A. L. (2013) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2012.12.012 · Cited by 16
Chen, M., Xie, C., Gao, H., Zheng, H., Chen, Q., & Fang, J. (2016) · BMJ Open · doi:10.1136/bmjopen-2015-010252 · Cited by 16
Is Australia ready to use glycated haemoglobin for the diagnosis of diabetes?
Shaw, J. E., dʼEmden, M. C., & Goodall, I. (2011) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.2011.tb03178.x · Cited by 16
Self-citationMatsha, T. E., Korf, M., Erasmus, R. T., Hoffmann, M., Mapfumo, C., Smit, F., & Zemlin, A. E. (2019) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1177/0004563219847234 · Cited by 15
Tomizawa, N., Inoh, S., Nojo, T., & Nakamura, S. (2015) · International journal of cardiac imaging · doi:10.1007/s10554-015-0788-6 · Cited by 15
Type 2 Diabetes Prevention: Implications of Hemoglobin A1c Genetics
Leong, A., & Meigs, J. B. (2015) · The Review of Diabetic Studies · doi:10.1900/rds.2015.12.351 · Cited by 15
Dankner, R. S., Bergman, M., Danoff, A., Qureshi, S., Whitford, I., Kaviani, N., Dynkevich, Y., & Roth, J. (2012) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2373 · Cited by 15
“study, HbA1c testing demonstrated similar sensitivity and specificity as fasting and post-load glucose measurements for predicting retinopathy [30].”
BackgroundHuang, H., Peng, G., Lin, M., Zhang, K., Wang, Y., Yu, Y., Zuo, Z., Chen, R., & Wang, J. (2013) · Preventive Medicine · doi:10.1016/j.ypmed.2013.06.012 · Cited by 15
Wu, Y., Hsu, C., Hwang, S., Lin, K., Lin, P.-C., Huang, Y., Lee, C., Chang, C.-I., & Huang, M. (2024) · Nutrients · doi:10.3390/nu16142274 · Cited by 14
Self-citationOpportunistic pathology-based screening for diabetes
Simpson, A. J., Krowka, R., Kerrigan, J., Southcott, E., Wilson, J. D., Potter, J. M., Nolan, C. J., & Hickman, P. E. (2013) · BMJ Open · doi:10.1136/bmjopen-2013-003411 · Cited by 14
Franco, L. J., Fabbro, A. L. D., Martínez, E. Z., Sartorelli, D. S., da Silva, A. S., Soares, L. P., Franco, L. F., Kuhn, P. C., Vieira‐Filho, J. P. B., & Moisés, R. S. (2014) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2014.08.027 · Cited by 14
Prevalence of retinopathy and its risk factors in a J apanese population
Fukushima, S., Nakagami, T., Suto, C., Hirose, A., & Uchigata, Y. (2013) · Journal of Diabetes Investigation · doi:10.1111/jdi.12044 · Cited by 14
Ji, L., Weng, J., Lu, J., Guo, X., Yang, W., Jia, W., Zou, D., Zhou, Z., Zhu, D., Ji, Q., et al. (2014) · Journal of Endocrinological Investigation · doi:10.1007/s40618-014-0115-4 · Cited by 13
Younes, N., Ghwairi, M. M. A., Da'as, S. I., Zaabi, E. A. A., Majdalawieh, A. F., Al-Dewik, N. I. E., & Nasrallah, G. K. (2023) · Frontiers in Bioscience-Landmark · doi:10.31083/j.fbl2803060 · Cited by 13
Almdal, T., Handlos, L. N., Valerius, M., Juul, E., Nielsen, K. E., Vistisen, D., Nielsen, L. B., Sheikh, A., Belhadj, M., Nadir, D., et al. (2014) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2013.12.023 · Cited by 13
EASD, E. (2013) · Kardiologia Polska · doi:10.5603/kp.2013.0289 · Cited by 13
Isolated post-challenge hyperglycaemia predicts increased cardiovascular mortality
Silbernagel, G., Sourij, H., Grammer, T. B., Kleber, M. E., Hartaigh, B. Ó., Winkelmann, B. R., Boehm, B. O., & März, W. (2012) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2012.08.008 · Cited by 13
Data-analytically derived flexible HbA1c thresholds for type 2 diabetes mellitus diagnostic
Stranieri, A., Yatsko, A., Jelinek, H. F., & Venkatraman, S. (2015) · Artificial Intelligence Research · doi:10.5430/air.v5n1p111 · Cited by 13
“Further, HbA1c levels have been shown to be strongly correlated with micro- and macro-vascular complications of T2DM, specifically retinopathy[9] and cardio-vascular disease.”
BackgroundZhang, X., Yang, Z., Zhang, M., Zhu, Y., Zhao, Z., Huang, Z., Li, C., Zhou, M., Farmer, A. A., Tang, J.-L., et al. (2021) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2021.108672 · Cited by 12
LC–MS/MS Analysis of Reaction Products of Arginine/Methylarginines with Methylglyoxal/Glyoxal
Rodda, R., Addipilli, R., Kannoujia, J., Lingampelly, S. S., & Prabhakar, S. (2023) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.3c00220 · Cited by 12
Senior, P. A. (2021) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2021.09.001 · Cited by 12
Mostafa, S. A., Khunti, K., Kilpatrick, E., Webb, D. R., Srinivasan, B. T., Gray, L. J., & Davies, M. J. (2012) · Diabetes and Vascular Disease Research · doi:10.1177/1479164112451473 · Cited by 12
Cattaneo, A., Vitali, A., Regazzoni, D., & Rizzi, C. (2024) · Studies in health technology and informatics · doi:10.3233/shti240014 · Cited by 11
Personal View: Should haemoglobin A1C be used for diagnosis of diabetes mellitus in Malawi?
Nakanga, W. P., Crampin, A. C., & Nyirenda, M. (2016) · Malawi Medical Journal · doi:10.4314/mmj.v28i1.7 · Cited by 11
Microvascular complications in prediabetes: a systematic review & meta-analysis
Thiab, S., Akhal, T., Akeblersane, M., Sheth, H., Atkin, S. L., & Butler, A. E. (2025) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2025.112261 · Cited by 10
Ethnic Variation in Diabetic Retinopathy Lesion Distribution on Ultra-widefield Imaging
He, Y., Verma, A., Nittala, M. G., Velaga, S. B., Esmaeilkhanian, H., Li, X., Su, L., Li, X., Jayadev, C., Tsui, I., et al. (2022) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2022.10.023 · Cited by 10
Bakhashab, S., Yeoh, M. L. Y., Coulson, D. J., Steel, S. C., Ray, S. L., & Weaver, J. U. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232415659 · Cited by 10
Chan, S. P., Lim, L., Chan, J. C. N., & Matthews, D. R. (2023) · Diabetes Therapy · doi:10.1007/s13300-023-01386-5 · Cited by 10
Cao, Y., Hardy, R., & Wulaningsih, W. (2019) · PLoS ONE · doi:10.1371/journal.pone.0211952 · Cited by 10
Association of Race/Ethnicity With Specific Glycemic Thresholds for Predicting Diabetic Retinopathy
Moore, K. J., Dunn, E. C., & Koru‐Sengul, T. (2019) · JAMA Ophthalmology · doi:10.1001/jamaophthalmol.2019.0024 · Cited by 10
Kabeza, C. B., Ntabadde, K., DuBose, C. W., Ha, J., Sherman, A., & Sumner, A. E. (2024) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2024.111792 · Cited by 9
HIV and type 2 diabetes: An evolving story
Daultrey, H. E., Levett, T. J., Oliver, N. S., Vera, J. H., & Chakera, A. J. (2023) · HIV Medicine · doi:10.1111/hiv.13595 · Cited by 9
“Most studies concentrate on the detection of moderate retinopathy, a degree of retinopathy more specific to diabetes [30].”
BackgroundFu, Y., Liang, X., Yang, X., Li, L., Meng, L., Wei, Y., Huang, D., & Qin, Y. (2024) · APL Bioengineering · doi:10.1063/5.0207658 · Cited by 9
Hadwen, J., Kim, W., Dewar, B., Ramsay, T., Davis, A., Dowlatshahi, D. D., & Shamy, M. C. F. (2021) · BMJ Open · doi:10.1136/bmjopen-2020-044771 · Cited by 9
Jarab, A. S., Al-Qerem, W. A., Hamam, H., Heshmeh, S. A., Al-Azzam, S. I., Mukattash, T. L., & Alefishat, E. A. (2023) · PLoS ONE · doi:10.1371/journal.pone.0285142 · Cited by 9
“Previous studies reported that poor glycemic control was associated with an increased risk of visual impairment [15], kidney failure [16], and CVDs, including HF [17].”
BackgroundPharmacotherapeutic options for prediabetes
Rendell, M. (2020) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2020.1817381 · Cited by 9
Anderson, J. J., Welsh, P. I., Ho, F. K. W., Ferguson, L. D., Welsh, C. E., Pellicori, P., Cleland, J. G. F., Forbes, J., Iliodromiti, S., Boyle, J., et al. (2021) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2021-002176 · Cited by 9
Bereda, G., & Bereda, G. (2021) · Diabetes Updates · doi:10.15761/du.1000155 · Cited by 9
Diabetes: an Overview for Clinical Oncologists
Lee, Y.-N., & Chowdhury, T. A. (2020) · Clinical Oncology · doi:10.1016/j.clon.2020.03.012 · Cited by 8
Shah, B. R., Feig, D. S., Herer, E., Hladunewich, M., Kiss, A., Kohly, R. P., Lipscombe, L. L., Yip, P. S. F., & Cherney, D. Z. I. (2021) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2021.109068 · Cited by 8
The Optimal Cutoff Value of Glycated Hemoglobin for Detection of Diabetic Retinopathy
Kim, J. M., & Kim, D. (2015) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2015.39.1.16 · Cited by 8
Ethnicity Considerations in Diagnosing Glucose Disorders
Hare, M. J. L., & Shaw, J. E. (2015) · Current Diabetes Reviews · doi:10.2174/1573399811666150211112455 · Cited by 8
Self-citationMathematical analysis of a model for glucose regulation
Fessel, K., Gaither, J., Bower, J. K., Gaillard, T. R., Osei, K., & Rempała, G. A. (2015) · Mathematical Biosciences & Engineering · doi:10.3934/mbe.2016.13.83 · Cited by 8
Iakunchykova, O. P., Averina, M., Wilsgaard, T., Malyutina, S. K., Kudryavtsev, A. V., Cook, S., Wild, S. H., Eggen, A. E., Hopstock, L. A., & Leon, D. A. (2021) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2020-002021 · Cited by 8
Zywicki, V., Capozza, P., Caravelli, P., Prato, S. D., & Caterina, R. D. (2022) · Cardiovascular Diabetology · doi:10.1186/s12933-022-01590-w · Cited by 8
Sharma, A., Nermoen, I., Qvigstad, E., Tran, A. T., Sommer, C., Sattar, N. A., Gill, J. M. R., Gulseth, H. L., Sollid, S. T., & Birkeland, K. I. (2022) · BMC Medicine · doi:10.1186/s12916-022-02515-w · Cited by 8
Longitudinal Validation of Hemoglobin A1c Criteria for Diabetes Diagnosis: Risk of Retinopathy
Sobrin, L. (2012) · Diabetes · doi:10.2337/db12-1226 · Cited by 8
Azam, M. E., Marwood, L., Ismail, K., Evans, T., Sivaprasad, S., Winkley, K., & Amiel, S. A. (2015) · Journal of Diabetes Research · doi:10.1155/2015/587673 · Cited by 7
Epidemiology, Risk Factors, and Pathophysiology of Diabetic Retinopathy
Bhagat, N., & Zarbin, M. A. (2018) · Springer eBooks · doi:10.1007/978-3-319-96157-6_1 · Cited by 7
How clinically relevant is statin-induced diabetes?
Gerstein, H. C., & Pigeyre, M. (2024) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(24)00059-7 · Cited by 7
Rakha, A., Rasheed, H., Altemimi, A. B., Tul‐Muntaha, S., Fatima, I., Butt, M. S., Hussain, S., Bhat, Z. F., Khaneghah, A. M., & Aadil, R. M. (2024) · Food Bioscience · doi:10.1016/j.fbio.2024.104195 · Cited by 7
Please call my contact person: mobile devices for a rescue mission during an emergency
Olaleye, S. A., Sanusi, I. T., Agjei, R. O., & Adusei‐Mensah, F. (2021) · Information Discovery and Delivery · doi:10.1108/idd-06-2020-0064 · Cited by 7
Oral glucose tolerance testing and cardiovascular disease
Rydén, L., Gyberg, V., Schnell, O., & Tuomilehto, J. (2016) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(16)30183-8 · Cited by 7
Is HbA1c a good diagnostic test for (pre)diabetes in cardiac rehabilitation patients?
Smulders, Y. M., & Serné, E. H. (2018) · European Journal of Preventive Cardiology · doi:10.1177/2047487318757553 · Cited by 7
Diagnosing diabetes mellitus from smartphone-based vascular signals
Klonoff, D. C. (2020) · Nature Reviews Endocrinology · doi:10.1038/s41574-020-00433-6 · Cited by 7
Metadata
- Authors
- Colagiuri, S., Lee, C. M. Y., Wong, T. Y., Balkau, B., Shaw, J. E., Borch-Johnsen, K., & the DETECT-2 Collaboration Writing Group
- Affiliations
- The University of Sydney (AU)
- The University of Melbourne (AU)
- Université Paris-Sud (FR)
- Baker Heart and Diabetes Institute (AU)
- Steno Diabetes Center, Gentofte, Denmark;
- Corresponding author
- Colagiuri, Stephen
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2010-10-26
- Volume
- 34
- Issue
- 1
- Pages
- 145-150
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC3005450
- OpenAlex
- W2134739555
- Cited by
- 300
- References
- 26
- Citations by year
- 2026: 7 · 2025: 10 · 2024: 18 · 2023: 18 · 2022: 21 · 2021: 20 · 2020: 21 · 2019: 13 · 2018: 23 · 2017: 12 · 2016: 23 · 2015: 26 · 2014: 25 · 2013: 30 · 2012: 20
- FWCI
- 21.69
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes Care (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Minerva Access (University of Melbourne) (submittedVersion, cc-by-nc-nd)
- National University of Singapore (submittedVersion)
- eSpace (Curtin University) (submittedVersion)
- Figshare (submittedVersion)
- University of Southern Denmark Research Portal (University of Southern Denmark) (submittedVersion)
- Funders
- Diabetes Australia Research Trust
- National Institutes of Health (n01hc55021-47-0-1, n01hc55020-39-0-0, n01hc55016-37-0-0, n01hc055022-024, n01hc55019-35-0-1, n01hc55018-38-0-1, n01hc55015-48-0-1)
- National Health and Medical Research Council
- National Heart, Lung, and Blood Institute (N01-HC55022, N01 HC055016, N01-HC-55018, N01 HC 55020, N01 HC 55019, N01 HC055020, N01 HC055018, N01-HC55016, N01 HC055022, N01 HC055019, N01‐HC‐55015, N01-HC55021, N01 HC055021, N01 HC055015)
- National Eye Institute
- National Institute of Diabetes and Digestive and Kidney Diseases
- Topics
- Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Retinal Imaging and Analysis
- Keywords
- diabetic retinopathy, glycemic thresholds, fasting blood glucose, 2-hour postprandial glucose, HbA1c, diabetes diagnostic criteria, glycemic control, fundus images
- MeSH terms
- Adult, Aged, Blood Glucose, Diabetic Retinopathy, Fasting, Glycated Hemoglobin, Humans, Middle Aged, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.